MedTrace Logo

Glucose-dependent Asprosin Dynamics

NCT03358121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2017-11-30

No results posted yet for this study

Summary

The study entitled " Asprosin Dynamics relating to serum Glucose levels under controlled alterations" investigates the dynamics of Asprosin in relation to glucose levels under controlled conditions in diabetic patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Clamp study

Clamp study to achieve high, normal, and lower glucose levels to study the dynamics of Asprosin.

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Stef Kopf, MD · Head of the Clinical Study Center for Diabetes Research

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-11
Primary Completion
2017-10-13
Completion
2017-10-13

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03358121 on ClinicalTrials.gov